Annual Working Capital
$530.63 M
-$40.41 M-7.08%
December 31, 2023
Summary
- As of February 7, 2025, RNA annual working capital is $530.63 million, with the most recent change of -$40.41 million (-7.08%) on December 31, 2023.
- During the last 3 years, RNA annual working capital has risen by +$213.54 million (+67.34%).
- RNA annual working capital is now -7.08% below its all-time high of $571.03 million, reached on December 31, 2022.
Performance
RNA Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$1.53 B
+$285.94 M+22.97%
September 1, 2024
Summary
- As of February 7, 2025, RNA quarterly working capital is $1.53 billion, with the most recent change of +$285.94 million (+22.97%) on September 1, 2024.
- Over the past year, RNA quarterly working capital has increased by +$1.02 billion (+202.02%).
- RNA quarterly working capital is now at all-time high.
Performance
RNA Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
RNA Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -7.1% | +202.0% |
| 3 y3 years | +67.3% | +283.1% |
| 5 y5 years | +10000.0% | - |
RNA Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -7.1% | +39.1% | at high | +313.0% |
| 5 y | 5-year | -7.1% | +521.0% | at high | +1839.5% |
| alltime | all time | -7.1% | >+9999.0% | at high | +1839.5% |
Avidity Biosciences Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.53 B(+23.0%) |
| Jun 2024 | - | $1.24 B(+44.8%) |
| Mar 2024 | - | $859.52 M(+62.0%) |
| Dec 2023 | $530.63 M(-7.1%) | $530.63 M(+4.7%) |
| Sep 2023 | - | $506.77 M(-7.7%) |
| Jun 2023 | - | $549.29 M(+0.0%) |
| Mar 2023 | - | $549.06 M(-3.8%) |
| Dec 2022 | $571.03 M | $571.03 M(+53.6%) |
| Sep 2022 | - | $371.80 M(+0.3%) |
| Jun 2022 | - | $370.56 M(-0.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $373.88 M(-2.0%) |
| Dec 2021 | $381.48 M(+20.3%) | $381.48 M(-4.5%) |
| Sep 2021 | - | $399.54 M(+47.4%) |
| Jun 2021 | - | $270.97 M(-8.0%) |
| Mar 2021 | - | $294.44 M(-7.1%) |
| Dec 2020 | $317.09 M(+271.1%) | $317.09 M(-4.1%) |
| Sep 2020 | - | $330.62 M(-3.4%) |
| Jun 2020 | - | $342.20 M(+333.6%) |
| Mar 2020 | - | $78.92 M(-7.6%) |
| Dec 2019 | $85.44 M(-6318.3%) | $85.44 M |
| Dec 2018 | -$1.37 M | - |
FAQ
- What is Avidity Biosciences annual working capital?
- What is the all time high annual working capital for Avidity Biosciences?
- What is Avidity Biosciences annual working capital year-on-year change?
- What is Avidity Biosciences quarterly working capital?
- What is the all time high quarterly working capital for Avidity Biosciences?
- What is Avidity Biosciences quarterly working capital year-on-year change?
What is Avidity Biosciences annual working capital?
The current annual working capital of RNA is $530.63 M
What is the all time high annual working capital for Avidity Biosciences?
Avidity Biosciences all-time high annual working capital is $571.03 M
What is Avidity Biosciences annual working capital year-on-year change?
Over the past year, RNA annual working capital has changed by -$40.41 M (-7.08%)
What is Avidity Biosciences quarterly working capital?
The current quarterly working capital of RNA is $1.53 B
What is the all time high quarterly working capital for Avidity Biosciences?
Avidity Biosciences all-time high quarterly working capital is $1.53 B
What is Avidity Biosciences quarterly working capital year-on-year change?
Over the past year, RNA quarterly working capital has changed by +$1.02 B (+202.02%)